Optellum's software tools identify, diagnose, and track lung disease patients to enable better outcomes through earlier interventions.
Optellum is building a next-generation diagnostic platform that uses advanced AI to automatically identify suspicious nodules on CT scans, enabling earlier and more accurate detection of lung cancer. By addressing the limitations of manual interpretation, Optellum helps clinicians make faster, more confident decisions and improve patient outcomes.
Optellum’s solution is FDA-approved, and the company collaborates with leading healthcare institutions to advance precision diagnosis and transform early lung cancer detection and treatment.
